Combining gene mutation with gene expression data improves outcome prediction in myelodysplastic syndromes
出版年份 2015 全文链接
标题
Combining gene mutation with gene expression data improves outcome prediction in myelodysplastic syndromes
作者
关键词
-
出版物
Nature Communications
Volume 6, Issue 1, Pages -
出版商
Springer Nature
发表日期
2015-01-09
DOI
10.1038/ncomms6901
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Regularization Paths for Generalized Linear Models via Coordinate Descent
- (2015) Jerome Friedman et al. Journal of Statistical Software
- Regularization Paths for Cox's Proportional Hazards Model via Coordinate Descent
- (2015) Noah Simon et al. Journal of Statistical Software
- Clinical and biological implications of driver mutations in myelodysplastic syndromes
- (2013) E. Papaemmanuil et al. BLOOD
- Silencing of ASXL1 impairs the granulomonocytic lineage potential of human CD34+progenitor cells
- (2013) Carwyn Davies et al. BRITISH JOURNAL OF HAEMATOLOGY
- Recent advances in understanding the molecular pathogenesis of myelodysplastic syndromes
- (2013) Austin G. Kulasekararaj et al. BRITISH JOURNAL OF HAEMATOLOGY
- Landscape of genetic lesions in 944 patients with myelodysplastic syndromes
- (2013) T Haferlach et al. LEUKEMIA
- Recurrent mutations in multiple components of the cohesin complex in myeloid neoplasms
- (2013) Ayana Kon et al. NATURE GENETICS
- Genomic and Epigenomic Landscapes of Adult De Novo Acute Myeloid Leukemia
- (2013) NEW ENGLAND JOURNAL OF MEDICINE
- Cancer Genome Landscapes
- (2013) B. Vogelstein et al. SCIENCE
- Mutations affecting mRNA splicing define distinct clinical phenotypes and correlate with patient outcome in myelodysplastic syndromes
- (2012) F. Damm et al. BLOOD
- Mutations in the spliceosome machinery, a novel and ubiquitous pathway in leukemogenesis
- (2012) H. Makishima et al. BLOOD
- ASXL1 Mutations Promote Myeloid Transformation through Loss of PRC2-Mediated Gene Repression
- (2012) Omar Abdel-Wahab et al. CANCER CELL
- The transporter ABCB7 is a mediator of the phenotype of acquired refractory anemia with ring sideroblasts
- (2012) M Nikpour et al. LEUKEMIA
- Molecular Pathophysiology of Myelodysplastic Syndromes
- (2011) R. Coleman Lindsley et al. Annual Review of Pathology-Mechanisms of Disease
- Clinical significance of SF3B1 mutations in myelodysplastic syndromes and myelodysplastic/myeloproliferative neoplasms
- (2011) L. Malcovati et al. BLOOD
- Unraveling the Molecular Pathophysiology of Myelodysplastic Syndromes
- (2011) Rafael Bejar et al. JOURNAL OF CLINICAL ONCOLOGY
- Gene expression profiling in MDS and AML: potential and future avenues
- (2011) K Theilgaard-Mönch et al. LEUKEMIA
- Mapping and analysis of chromatin state dynamics in nine human cell types
- (2011) Jason Ernst et al. NATURE
- Silencing chromatin: comparing modes and mechanisms
- (2011) Christian Beisel et al. NATURE REVIEWS GENETICS
- Exploring the Genomes of Cancer Cells: Progress and Promise
- (2011) M. R. Stratton SCIENCE
- Molecular Biology of Myelodysplastic Syndromes
- (2011) Alan H. Shih et al. SEMINARS IN ONCOLOGY
- Genetics of Myelodysplastic Syndromes: New Insights
- (2011) T. Graubert et al. Hematology-American Society of Hematology Education Program
- Deregulated gene expression pathways in myelodysplastic syndrome hematopoietic stem cells
- (2010) A Pellagatti et al. LEUKEMIA
- The NIH Roadmap Epigenomics Mapping Consortium
- (2010) Bradley E Bernstein et al. NATURE BIOTECHNOLOGY
- Relationship of differential gene expression profiles in CD34+ myelodysplastic syndrome marrow cells to disease subtype and progression
- (2009) K. Sridhar et al. BLOOD
- Microarray-based classifiers and prognosis models identify subgroups with distinct clinical outcomes and high risk of AML transformation of myelodysplastic syndrome
- (2009) K. I. Mills et al. BLOOD
- Random survival forests
- (2008) Hemant Ishwaran et al. Annals of Applied Statistics
- Comprehensive genomic characterization defines human glioblastoma genes and core pathways
- (2008) Roger McLendon et al. NATURE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started